FamGenix is a Health Care and Information Technology startup, founded in 2018 and headquartered in the United States. The company offers pedigree and risk assessment solutions for healthcare providers and patients to evaluate the risk of hereditary diseases. Its mobile-friendly app, FamGenix, empowers patients to manage their family histories and track crucial health history data to determine their risk for inherited diseases. Additionally, the Provider Portal enables clinicians to triage, screen, and communicate with patients, as well as view auto-generated pedigrees. FamGenix automatically identifies patients suitable for genetic counseling or testing, and clinicians can run further risk models to determine lifetime risk for certain hereditary cancers. With a focus on #familyhealthhistory, #hereditarycancer, #genetics, #genomics, and #precisionmedicine, FamGenix is positioned at the forefront of genetic counseling and hereditary disease risk assessment. For more information about the app, visit famgenix.com.
There is no investment information
No recent news or press coverage available for FamGenix.